(-)-cotinine increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Cotinine CTD PMID:16141602 (5Z,8Z,11Z,13E)-15-HETE increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 15-hydroxy-5 more ... CTD PMID:15231852 (S)-naringenin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of naringenin CTD PMID:14557274 , PMID:18816295 (S)-nicotine increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Nicotine CTD PMID:14570768 , PMID:16141602 1-Hydroxypyrene increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 1-hydroxypyrene CTD PMID:15802387 1-naphthol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 1-naphthol CTD PMID:15044611 , PMID:18816295 1-naphthylamine decreases activity ISO RGD:1348090 6480464 1-Naphthylamine results in decreased activity of UGT1A9 protein CTD PMID:14744740 17beta-estradiol decreases activity ISO RGD:1348090 6480464 Estradiol results in decreased activity of UGT1A9 protein CTD PMID:15378558 17beta-estradiol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Estradiol, UGT1A9 protein results in increased glucuronidation of Estradiol analog CTD PMID:15472229 2',4,4',6'-tetrahydroxychalcone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of naringenin chalcone CTD PMID:14557274 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1619653 6480464 2 more ... CTD PMID:17964624 2,3,7,8-tetrachlorodibenzodioxine increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Tetrachlorodibenzodioxin metabolite CTD PMID:15258113 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1619653 6480464 Tetrachlorodibenzodioxin results in increased expression of UGT1A7 mRNA, Tetrachlorodibenzodioxin results in increased expression of UGT1A9 mRNA CTD PMID:19144771 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1619653 6480464 Tetrachlorodibenzodioxin affects the expression of UGT1A9 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1348090 6480464 Tetrachlorodibenzodioxin results in increased expression of UGT1A9 mRNA CTD PMID:10220484 , PMID:16155002 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1619653 6480464 [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of UGT1A9 mRNA more ... CTD PMID:19474220 , PMID:22496397 2-acetamidofluorene increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 2-Acetylaminofluorene analog CTD PMID:11375903 2-hydroxyestrone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 2-hydroxyestrone CTD PMID:15117964 2-methoxy-17beta-estradiol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 2-Methoxyestradiol CTD PMID:15117964 2-tert-butylhydroquinone increases expression ISO RGD:1348090 6480464 2-tert-butylhydroquinone results in increased expression of UGT1A9 mRNA CTD PMID:10220484 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1619653 6480464 3 more ... CTD PMID:19144771 3-methylcholanthrene increases expression ISO RGD:1348090 6480464 Methylcholanthrene results in increased expression of UGT1A9 mRNA CTD PMID:19118567 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:31307193 4-hydroxyestrone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 4-hydroxyestrone CTD PMID:15117964 4-hydroxyphenytoin multiple interactions ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of and results in decreased activity of hydroxyphenytoin CTD PMID:15855726 4-methylumbelliferone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Hymecromone CTD PMID:15378558 , PMID:15802387 4-methylumbelliferone increases metabolic processing ISO RGD:1348090 6480464 UGT1A9 protein results in increased metabolism of Hymecromone CTD PMID:31812603 4-methylumbelliferone multiple interactions ISO RGD:1348090 6480464 [UGT1A9 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide more ... CTD PMID:26875642 , PMID:31812603 4-methylumbelliferone increases activity ISO RGD:1348090 6480464 Hymecromone results in increased activity of UGT1A9 protein CTD PMID:26875642 4-methylumbelliferone beta-D-glucuronide multiple interactions ISO RGD:1348090 6480464 [UGT1A9 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide, pterostilbene inhibits the reaction [[UGT1A9 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] CTD PMID:31812603 4-nitrophenol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 4-nitrophenol CTD PMID:15044611 , PMID:15802387 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression ISO RGD:1348090 6480464 Omeprazole results in increased expression of UGT1A9 mRNA CTD PMID:19118567 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of UGT1A9 mRNA CTD PMID:24780913 , PMID:25825206 aflatoxin B1 decreases methylation ISO RGD:1348090 6480464 Aflatoxin B1 results in decreased methylation of UGT1A9 gene CTD PMID:27153756 alizarin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of alizarin CTD PMID:14557274 Aloe emodin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of aloe emodin CTD PMID:24854283 amentoflavone decreases activity ISO RGD:1348090 6480464 amentoflavone results in decreased activity of UGT1A9 protein CTD PMID:29470958 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of UGT1A9 mRNA CTD PMID:16483693 amphotericin B affects expression EXP 6480464 Amphotericin B affects the expression of UGT1A9 mRNA CTD PMID:20623750 anthraflavic acid increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 2, 6-dihydroxyanthraquinone CTD PMID:14557274 anthrarobin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of anthrarobin CTD PMID:14557274 apigenin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Apigenin CTD PMID:14557274 arachidonic acid increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Arachidonic Acid CTD PMID:15231852 arsenous acid decreases expression ISO RGD:1348090 6480464 Arsenic Trioxide results in decreased expression of UGT1A9 mRNA CTD PMID:17530438 benoxaprofen affects response to substance ISO RGD:1348090 6480464 UGT1A9 affects the susceptibility to benoxaprofen CTD PMID:17880178 benzo[a]pyrene increases expression ISO RGD:1619653 6480464 Benzo(a)pyrene results in increased expression of UGT1A9 mRNA CTD PMID:19770486 , PMID:20127859 benzo[a]pyrene multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Benzo(a)pyrene promotes the reaction [Phenobarbital results in increased expression of UGT1A9 mRNA]] more ... CTD PMID:25489928 benzo[a]pyrene increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Benzo(a)pyrene CTD PMID:14557274 benzo[a]pyrene affects response to substance ISO RGD:1348090 6480464 UGT1A9 protein affects the susceptibility to Benzo(a)pyrene CTD PMID:21507987 benzo[a]pyrene increases expression ISO RGD:1348090 6480464 Benzo(a)pyrene results in increased expression of UGT1A9 mRNA, Benzo(a)pyrene results in increased expression of UGT1A9 protein CTD PMID:21507987 benzo[a]pyrene multiple interactions ISO RGD:1348090 6480464 Benzo(a)pyrene promotes the reaction [[BRCA1 protein binds to UGT1A9 promoter] which results in increased expression of UGT1A9 mRNA] more ... CTD PMID:21507987 bergomottin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of bergamottin analog CTD PMID:14557274 beta-naphthoflavone increases expression ISO RGD:1348090 6480464 beta-Naphthoflavone results in increased expression of UGT1A9 mRNA CTD PMID:17917264 , PMID:19118567 beta-naphthoflavone increases expression ISO RGD:1619653 6480464 beta-Naphthoflavone results in increased expression of UGT1A9 mRNA CTD PMID:19144771 bezafibrate increases response to substance ISO RGD:1348090 6480464 UGT1A9 results in increased susceptibility to Bezafibrate CTD PMID:17880178 biochanin A increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of biochanin A CTD PMID:14557274 biphenyl-4-amine increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 4-biphenylamine CTD PMID:15840509 biphenyl-4-amine multiple interactions ISO RGD:1348090 6480464 [Alamethicin results in increased activity of UGT1A9 protein] which affects the glucuronidation of 4-biphenylamine CTD PMID:17080401 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1619653 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of UGT1A9 mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1619653 6480464 Diethylhexyl Phthalate results in increased expression of UGT1A9 mRNA CTD PMID:19850644 bisphenol A decreases expression ISO RGD:1348090 6480464 bisphenol A results in decreased expression of UGT1A9 mRNA CTD PMID:24214726 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of UGT1A9 mRNA CTD PMID:26496021 bisphenol A increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein polymorphism results in increased glucuronidation of bisphenol A, UGT1A9 protein results in increased glucuronidation of bisphenol A CTD PMID:18990428 , PMID:26999266 Bropirimine increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of bropirimine CTD PMID:14555337 buta-1,3-diene increases expression ISO RGD:1619653 6480464 1, 3-butadiene results in increased expression of UGT1A9 mRNA CTD PMID:29038090 calycosin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 7, 3'-dihydroxy-4'-methoxyisoflavone CTD PMID:25044472 capsaicin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Capsaicin CTD PMID:14557274 chenodeoxycholic acid decreases expression ISO RGD:1348090 6480464 Chenodeoxycholic Acid results in decreased expression of UGT1A9 mRNA CTD PMID:27174168 chrysin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of chrysin CTD PMID:14557274 chrysin affects glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein affects the glucuronidation of chrysin CTD PMID:10950852 chrysophanol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of chrysophanic acid CTD PMID:24854283 ciglitazone multiple interactions ISO RGD:1348090 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of UGT1A9 mRNA CTD PMID:16197558 ciprofibrate increases expression ISO RGD:1619653 6480464 ciprofibrate results in increased expression of UGT1A9 mRNA CTD PMID:19144771 cisplatin multiple interactions ISO RGD:1348090 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of UGT1A9 mRNA CTD PMID:27392435 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Thyroxine] results in increased activity of UGT1A9 protein CTD PMID:18219302 clofibrate increases expression ISO RGD:1619653 6480464 Clofibrate results in increased expression of UGT1A9 mRNA CTD PMID:19144771 , PMID:22496397 clofibrate multiple interactions ISO RGD:1619653 6480464 PPARA protein affects the reaction [Clofibrate results in increased expression of UGT1A9 mRNA] CTD PMID:22496397 clofibric acid affects response to substance ISO RGD:1348090 6480464 UGT1A9 affects the susceptibility to Clofibric Acid CTD PMID:17880178 coumestrol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Coumestrol CTD PMID:14557274 curcumin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Curcumin CTD PMID:14557274 cyproconazole increases expression ISO RGD:1619653 6480464 cyproconazole results in increased expression of UGT1A9 mRNA CTD PMID:22334560 daidzein increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of daidzein CTD PMID:14557274 dexamethasone increases expression ISO RGD:1619653 6480464 Dexamethasone results in increased expression of UGT1A9 mRNA CTD PMID:19144771 Diallyl sulfide increases expression ISO RGD:1619653 6480464 allyl sulfide results in increased expression of UGT1A9 mRNA CTD PMID:19144771 diarsenic trioxide decreases expression ISO RGD:1348090 6480464 Arsenic Trioxide results in decreased expression of UGT1A9 mRNA CTD PMID:17530438 dibenzo[a,l]pyrene increases glycosylation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glycosylation of dibenzo(a, l)pyrene CTD PMID:21780761 dichloroacetic acid increases expression ISO RGD:1619653 6480464 Dichloroacetic Acid results in increased expression of UGT1A9 mRNA CTD PMID:28962523 diclofenac increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Diclofenac CTD PMID:15988124 dimethyl sulfoxide affects expression ISO RGD:1348090 6480464 Dimethyl Sulfoxide affects the expression of UGT1A9 mRNA CTD PMID:12843640 emodin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Emodin CTD PMID:14557274 , PMID:24854283 entacapone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of entacapone CTD PMID:15044611 more ... entacapone decreases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein mutant form results in decreased glucuronidation of entacapone CTD PMID:16344532 epoxiconazole increases expression ISO RGD:1619653 6480464 epoxiconazole results in increased expression of UGT1A9 mRNA CTD PMID:22334560 equol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Equol CTD PMID:14557274 estrone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Estrone, UGT1A9 protein results in increased glucuronidation of Estrone analog CTD PMID:15472229 etodolac increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Etodolac CTD PMID:15535975 eugenol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Eugenol CTD PMID:14557274 farnesol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Farnesol CTD PMID:15320866 fipronil increases expression ISO RGD:1619653 6480464 fipronil results in increased expression of UGT1A9 mRNA CTD PMID:23962444 fisetin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of fisetin CTD PMID:14557274 fluconazole affects expression EXP 6480464 Fluconazole affects the expression of UGT1A9 mRNA CTD PMID:20623750 flurbiprofen increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Flurbiprofen CTD PMID:15843492 formononetin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of formononetin CTD PMID:14557274 galangin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of galangin CTD PMID:14557274 genistein increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Genistein CTD PMID:14557274 , PMID:15988124 gentamycin affects expression EXP 6480464 Gentamicins affects the expression of UGT1A9 mRNA CTD PMID:20623750 glabridin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of glabridin CTD PMID:25765239 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of UGT1A9 mRNA CTD PMID:24915197 Grepafloxacin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of grepafloxacin CTD PMID:15769885 ibuprofen increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Ibuprofen CTD PMID:15843492 indometacin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Indomethacin CTD PMID:15843492 irinotecan increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Irinotecan CTD PMID:15833930 , PMID:17898154 irinotecan increases glucuronidation EXP 6480464 UGT1A9 protein results in increased glucuronidation of Irinotecan CTD PMID:15833930 isoliquiritigenin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of isoliquiritigenin CTD PMID:14557274 kaempferol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of kaempferol CTD PMID:14557274 ketoprofen increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Ketoprofen CTD PMID:15535975 , PMID:15843492 L-ascorbic acid multiple interactions ISO RGD:1348090 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of UGT1A9 mRNA CTD PMID:17639512 lorcaserin multiple interactions ISO RGD:1348090 6480464 UGT1A9 protein results in increased carbamoylation of and results in increased glucuronidation of lorcaserin CTD PMID:22259019 Magnolol decreases activity ISO RGD:1348090 6480464 magnolol results in decreased activity of UGT1A9 protein CTD PMID:26875642 mangiferin increases expression ISO RGD:1348090 6480464 mangiferin results in increased expression of UGT1A9 mRNA CTD PMID:22815239 masoprocol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Masoprocol CTD PMID:14557274 methotrexate decreases expression ISO RGD:1348090 6480464 Methotrexate results in decreased expression of UGT1A9 mRNA CTD PMID:20854796 methoxychlor increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Methoxychlor metabolite CTD PMID:15205390 mono(2-ethylhexyl) phthalate increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of mono-(2-ethylhexyl)phthalate CTD PMID:27071666 morin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of morin CTD PMID:14557274 morphine increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Morphine CTD PMID:12920162 moxifloxacin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of moxifloxacin CTD PMID:15769885 mycophenolic acid increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Mycophenolic Acid CTD PMID:18816295 , PMID:31742356 mycophenolic acid multiple interactions ISO RGD:1348090 6480464 4-cresol inhibits the reaction [[UGT1A9 protein results in increased glucuronidation of Mycophenolic Acid] which results in increased abundance of mycophenolic acid glucuronide] more ... CTD PMID:31742356 mycophenolic acid affects metabolic processing ISO RGD:1348090 6480464 UGT1A9 gene SNP affects the metabolism of Mycophenolic Acid CTD PMID:18498916 N-butyl-N-(4-hydroxybutyl)nitrosamine decreases expression ISO RGD:1619653 6480464 Butylhydroxybutylnitrosamine results in decreased expression of UGT1A7 mRNA CTD PMID:15374950 N-butyl-N-(4-hydroxybutyl)nitrosamine multiple interactions ISO RGD:1619653 6480464 oltipraz inhibits the reaction [Butylhydroxybutylnitrosamine results in decreased expression of UGT1A7 mRNA] CTD PMID:15374950 N-hydroxy-PhIP multiple interactions ISO RGD:1348090 6480464 UGT1A9 protein promotes the reaction [2-hydroxyamino-1-methyl-6-phenylimidazo(4, 5-b)pyridine binds to Glucuronides] CTD PMID:15986396 N-hydroxy-PhIP increases metabolic processing ISO RGD:1348090 6480464 UGT1A9 protein results in increased metabolism of 2-hydroxyamino-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:15986396 N-hydroxy-PhIP increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:11375903 , PMID:15310245 naproxen increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Naproxen CTD PMID:15535975 nicotine increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Nicotine CTD PMID:14570768 , PMID:16141602 obeticholic acid decreases expression ISO RGD:1348090 6480464 obeticholic acid results in decreased expression of UGT1A9 mRNA CTD PMID:27939613 ofloxacin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Ofloxacin CTD PMID:15769885 oltipraz multiple interactions ISO RGD:1619653 6480464 oltipraz inhibits the reaction [Butylhydroxybutylnitrosamine results in decreased expression of UGT1A7 mRNA] CTD PMID:15374950 omeprazole increases expression ISO RGD:1348090 6480464 Omeprazole results in increased expression of UGT1A9 mRNA CTD PMID:19118567 oxazepam increases metabolic processing ISO RGD:1348090 6480464 UGT1A9 protein results in increased metabolism of Oxazepam CTD PMID:12386133 p-cresol multiple interactions ISO RGD:1348090 6480464 4-cresol inhibits the reaction [[UGT1A9 protein results in increased glucuronidation of Mycophenolic Acid] which results in increased abundance of mycophenolic acid glucuronide], [4-cresol inhibits the reaction [[UGT1A9 protein results in increased glucuronidation of Mycophenolic Acid] which results in increased abundance of mycophenolic acid glucuronide]] which results in increased abundance of Mycophenolic Acid CTD PMID:31742356 paracetamol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Acetaminophen CTD PMID:17898154 paracetamol decreases expression ISO RGD:1348090 6480464 Acetaminophen results in decreased expression of UGT1A9 mRNA CTD PMID:29067470 perfluorooctanoic acid affects expression ISO RGD:1619653 6480464 perfluorooctanoic acid affects the expression of UGT1A9 mRNA CTD PMID:18281256 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of UGT1A9 mRNA CTD PMID:19631232 phenobarbital multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Benzo(a)pyrene promotes the reaction [Phenobarbital results in increased expression of UGT1A9 mRNA]] more ... CTD PMID:19631232 , PMID:25489928 physcion increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of physcione CTD PMID:24854283 pirinixic acid multiple interactions EXP 6480464 pirinixic acid promotes the reaction [Phenobarbital results in increased expression of UGT1A9 mRNA] CTD PMID:19631232 plumbagin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of plumbagin CTD PMID:14557274 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1348090 6480464 Pregnenolone Carbonitrile results in increased expression of UGT1A9 mRNA CTD PMID:16155002 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1619653 6480464 Pregnenolone Carbonitrile results in increased expression of UGT1A7 mRNA, Pregnenolone Carbonitrile results in increased expression of UGT1A9 mRNA CTD PMID:19144771 , PMID:22496397 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1619653 6480464 [Pregnenolone Carbonitrile results in increased activity of NR1I2 protein] which results in increased expression of UGT1A9 mRNA, NR1I2 protein affects the reaction [Pregnenolone Carbonitrile results in increased expression of UGT1A9 mRNA] CTD PMID:22496397 probenecid affects response to substance ISO RGD:1348090 6480464 UGT1A9 affects the susceptibility to Probenecid CTD PMID:17880178 propiconazole increases expression ISO RGD:1619653 6480464 propiconazole results in increased expression of UGT1A9 mRNA CTD PMID:22334560 propofol decreases activity ISO RGD:1348090 6480464 Propofol results in decreased activity of UGT1A9 protein CTD PMID:15378558 propofol multiple interactions ISO RGD:1348090 6480464 [Warfarin binds to and affects the activity of UGT1A9 protein] which affects the glucuronidation of Propofol more ... CTD PMID:25393417 more ... propofol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Propofol CTD PMID:12756209 more ... propofol affects metabolic processing ISO RGD:1348090 6480464 UGT1A9 protein affects the metabolism of Propofol CTD PMID:15286053 prostaglandin B1 increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of prostaglandin B1 CTD PMID:15231852 pterostilbene affects glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein affects the glucuronidation of pterostilbene CTD PMID:23965644 pterostilbene decreases activity ISO RGD:1348090 6480464 pterostilbene results in decreased activity of UGT1A9 protein CTD PMID:31812603 pterostilbene multiple interactions ISO RGD:1348090 6480464 pterostilbene inhibits the reaction [[UGT1A9 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] CTD PMID:31812603 puerarin increases metabolic processing ISO RGD:1348090 6480464 UGT1A9 protein results in increased metabolism of puerarin CTD PMID:22648071 quercetin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Quercetin CTD PMID:14557274 quercetin multiple interactions ISO RGD:1348090 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of UGT1A9 mRNA CTD PMID:17639512 quinizarin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 1, 4-dihydroxyanthraquinone CTD PMID:14557274 resveratrol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of resveratrol CTD PMID:17991766 , PMID:23965644 rifampicin increases expression ISO RGD:1348090 6480464 Rifampin results in increased expression of UGT1A9 mRNA, Rifampin results in increased expression of UGT1A9 protein CTD PMID:25070100 sarpogrelate increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of sarpogrelate metabolite CTD PMID:23704698 scopoletin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Scopoletin CTD PMID:15044611 , PMID:15802387 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of UGT1A9 mRNA CTD PMID:15967596 Shikonin multiple interactions ISO RGD:1348090 6480464 shikonin inhibits the reaction [UGT1A9 protein results in increased glucuronidation of Propofol] CTD PMID:31128210 silibinin multiple interactions ISO RGD:1348090 6480464 Silybin inhibits the reaction [UGT1A9 protein results in increased glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin] CTD PMID:15155549 Sitafloxacin increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of sitafloxacin CTD PMID:15769885 spironolactone increases expression ISO RGD:1619653 6480464 Spironolactone results in increased expression of UGT1A9 mRNA CTD PMID:19144771 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of UGT1A9 mRNA CTD PMID:26496021 thymol increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Thymol CTD PMID:14557274 thymol sulfate(1-) increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Thymol CTD PMID:14557274 thyroxine multiple interactions EXP 6480464 [Clofibrate co-treated with Thyroxine] results in increased activity of UGT1A9 protein CTD PMID:18219302 tolcapone decreases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein mutant form results in decreased glucuronidation of tolcapone CTD PMID:16344532 tolcapone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of tolcapone CTD PMID:16344532 triclocarban increases expression ISO RGD:1348090 6480464 triclocarban results in increased expression of UGT1A9 mRNA CTD PMID:22761658 triclocarban multiple interactions ISO RGD:1348090 6480464 NR1I3 gene mutant form inhibits the reaction [triclocarban results in increased expression of UGT1A9 mRNA] CTD PMID:22761658 umbelliferone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of 7-hydroxycoumarin CTD PMID:15044611 ursodeoxycholic acid increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Ursodeoxycholic Acid CTD PMID:31299240 valproic acid decreases expression ISO RGD:1348090 6480464 Valproic Acid results in decreased expression of UGT1A9 mRNA CTD PMID:29501571 vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of UGT1A9 mRNA CTD PMID:28923436 warfarin multiple interactions ISO RGD:1348090 6480464 [Warfarin binds to and affects the activity of UGT1A9 protein] which affects the glucuronidation of Propofol more ... CTD PMID:25393417 zearalenone increases glucuronidation ISO RGD:1348090 6480464 UGT1A9 protein results in increased glucuronidation of Zearalenone CTD PMID:14557274
Gene-Chemical Interaction Annotations
